[Radiosensitization induced by vemurafenib].

  title={[Radiosensitization induced by vemurafenib].},
  author={Anne Ducassou and Isabelle David and Martine Delannes and Christine Chevreau and Vincent Sibaud},
  journal={Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique},
  volume={17 4},
The recent use of vemurafenib, a specific inhibitor of BRAF, has led to a significant improvement in disease-free survival and overall survival of patients treated for a BRAF-mutated metastatic melanoma. This new class of drugs is not devoid of side effects, including skin effects. In particular, its association with concomitant radiotherapy should be taken into consideration, vemurafenib appearing to be radiosensitizer. The radiation oncologist must be aware of this potential toxicity, which… CONTINUE READING

From This Paper

Topics from this paper.


Publications citing this paper.
Showing 1-8 of 8 extracted citations

[Radiotherapy and targeted therapy/immunotherapy].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique • 2016
View 2 Excerpts

Similar Papers

Loading similar papers…